Ultima Genomics increases output by over 50% and lowers sequencing costs by a further 20% with the introduction of UG 100 Solaris™

• Commercial launch of UG 100 Solaris which includes new chemistry, software, and simplified workflows for the UG 100 sequencing platform, now with expanded applications support and integration with leading 'omics' technologies
• Over 50% increase in output to 10 to 12 billion reads per wafer and pricing reduced by 20% to $0.24 per million reads, enabling the $80 genome
• Increased sensitivity with 5X yield improvement for the SNVQ60 ppmSeq^™ mode enabling 30X coverage from as little as 2 nanograms of DNA (1/5th of the cfDNA found in a standard tube of blood)
• Early access availability of UG 100 Solaris Boost, a new high-throughput operating mode providing up to 100 billion reads per day for select short-read applications

FREMONT, Calif., Feb. 24, 2025 -- Ultima Genomics, Inc., a developer of an ultra-high-throughput sequencing architecture, today announced the commercial launch of UG 100 Solaris at the Advances in Genome Biology and Technology (AGBT) Conference on February 24, 2025. UG 100 Solaris features new chemistry, software, and simplified workflows to significantly increase output and lower cost on the UG 100 sequencing platform.